86 related articles for article (PubMed ID: 5022146)
21. [Treatment of atherosclerosis by pyridinolcarbamate. Review of the history of the introduction of pyridinolcarbamate and its clinical results].
Shimamoto T
Rev Atheroscler (Paris); 1968; 10(3):67-84. PubMed ID: 5746502
[No Abstract] [Full Text] [Related]
22. [Synthetic studies on antiatherogenic agents (II) syntheses of carbamate derivative of phthalazinones (author's transl)].
Ishikawa M; Egughi Y; Sugimoto A
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1975; 9():145-68. PubMed ID: 1076757
[No Abstract] [Full Text] [Related]
23. [Synthetic studies on antiatherogenic agents (III) syntheses of carbamate derivative of quinazolinones (author's transl)].
Ishikawa M; Egughi Y; Kaneshiro S
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1975; 9():169-81. PubMed ID: 1076758
[No Abstract] [Full Text] [Related]
24. [Pyridinol carbamate, a new approach in the prevention and therapy of atherosclerosis].
Etchevés JC; Buzzi RM; Bruno E; Sacanell C
Hospital (Rio J); 1968 Sep; 74(3):807-14. PubMed ID: 5310120
[No Abstract] [Full Text] [Related]
25. [Preliminary study of a work concerning the activity of pyridinol carbamate on diabetic angiopathy (study of the microcirculation)].
Le Devehat C; Lemoine A
Journ Annu Diabetol Hotel Dieu; 1977; ():389-93. PubMed ID: 894879
[No Abstract] [Full Text] [Related]
26. Pyridinolcarbamate in the treatment of ischemic heart diseases. A double blind study.
Guzman SV
Jpn Heart J; 1972 Jan; 13(1):53-8. PubMed ID: 4624307
[No Abstract] [Full Text] [Related]
27. [The effect of ximedon on cholesterol metabolism and experimental atherosclerosis in rabbits].
Dautova GS; Kosykh VA; Repin VS; Kamburg RA; Ibragimov OB; Popova LG; Valeeva IKh
Eksp Klin Farmakol; 1995; 58(1):25-9. PubMed ID: 7787689
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of pyridinol carbamate. I. Gas chromatographic determination of pyridinol carbamate].
Laukó A; Görög S
Acta Pharm Hung; 1986 May; 56(3):129-32. PubMed ID: 3739725
[No Abstract] [Full Text] [Related]
29. [Modifications of dyslipemia of atherosclerotic origin using pentosan polysulphonic ester].
Kabanchik M; Fernández F; Sermukslis B; Smud R; Palermo G
Prensa Med Argent; 1967 Dec; 54(39):2137-42. PubMed ID: 4901929
[No Abstract] [Full Text] [Related]
30. [New drugs registered in Austria].
Wien Klin Wochenschr; 1972 Mar; 84(12):200-1. PubMed ID: 5012428
[No Abstract] [Full Text] [Related]
31. [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies].
Tardito E; Trezzi M; Papackaralambus D
Minerva Cardioangiol; 1970 Dec; 18(12):692-705. PubMed ID: 5532336
[No Abstract] [Full Text] [Related]
32. [Synthetic studies on antiatherogenic agents (I). Syntheses of carbamate derivatives of diazines (author's transl)].
Ishikawa M; Eguchi Y
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1974; 8():9-20. PubMed ID: 4534365
[No Abstract] [Full Text] [Related]
33. [Treatment of arteriosclerosis].
Knüchel F
Med Welt; 1969 Dec; 52():2817-8. PubMed ID: 5371544
[No Abstract] [Full Text] [Related]
34. [Clinical experiences with pyridinolcarbamate in ophthalmology].
Musini A; Fabbri G; Tancini G
Ann Ottalmol Clin Ocul; 1969 Feb; 95(2):101-23. PubMed ID: 5398786
[No Abstract] [Full Text] [Related]
35. [Prodectin treatment of partial hearing loss as a result of atherosclerosis].
Smirnova NA; Timakov VA; Mikushkin MK
Vestn Otorinolaringol; 1982; (6):53-6. PubMed ID: 7179649
[No Abstract] [Full Text] [Related]
36. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
Orbetzova V; Jurukova Z; Orbetzova M
Artery; 1980; 8(6):560-9. PubMed ID: 7259535
[TBL] [Abstract][Full Text] [Related]
37. [New chemical substances for therapeutic use].
Clin Ter; 1970 Mar; 52(6):571-4. PubMed ID: 5452999
[No Abstract] [Full Text] [Related]
38. The effects of piridinol carbamate on hypercholesteremia and aortal damage produced by 5 days' application of Altman's diet to the rat.
Iwanowska J; Starzyński S; Kalinowska A
Pol J Pharmacol Pharm; 1980; 32(3):333-41. PubMed ID: 6974352
[TBL] [Abstract][Full Text] [Related]
39. Study of the effect of N-methyl carbamate on the electroencephalogram in cerebral arteriosclerosis.
Mori A; Ishikawa Y; Mukoyama K
Jpn Heart J; 1967 May; 8(3):234-41. PubMed ID: 5299490
[No Abstract] [Full Text] [Related]
40. [Therapy of hypercholesteremia using beta-pyridylcarbinol in reduced dosage].
Kaatzsch H
Med Welt; 1972 May; 23(22):836-7. PubMed ID: 5045322
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
